Article révisé par les pairs
Résumé : Objective: Drug resistance is a major concern in the treatment of individuals with epilepsy. No genetic markers for resistance to individual antiseizure medication (ASM) have yet been identified. We aimed to identify the role of rare genetic variants in drug resistance for three common ASMs: levetiracetam (LEV), lamotrigine (LTG), and valproic acid (VPA). Methods: A cohort of 1622 individuals of European descent with epilepsy was deeply phenotyped and underwent whole exome sequencing (WES), comprising 575 taking LEV, 826 LTG, and 782 VPA. We performed gene- and gene set–based collapsing analyses comparing responders and nonresponders to the three drugs to determine the burden of different categories of rare genetic variants. Results: We observed a marginally significant enrichment of rare missense, truncating, and splice region variants in individuals who were resistant to VPA compared to VPA responders for genes involved in VPA pharmacokinetics. We also found a borderline significant enrichment of truncating and splice region variants in the synaptic vesicle glycoprotein (SV2) gene family in nonresponders compared to responders to LEV. We did not see any significant enrichment using a gene-based approach. Significance: In our pharmacogenetic study, we identified a slightly increased burden of damaging variants in gene groups related to drug kinetics or targeting in individuals presenting with drug resistance to VPA or LEV. Such variants could thus determine a genetic contribution to drug resistance.

Documents en relation

DI-fusion

  • Pharmacoresponse in genetic generalized epilepsy: a genome-wide association study
    par Wolking, Stefan , Schulz, Herbert , Nies, Anne A.T. , McCormack, Mark , Schaeffeler, Elke , Auce, Pauls , Avbersek, Andreja , Becker, Felicitas , Klein, Karl Martin , Krenn, Martin , Møller, Rikke Steensbjerre , Nikanorova, Marina , Weckhuysen, Sarah , Consortium, Epi PGx , Cavalleri, Gianpiero , Delanty, Norman , Depondt, Chantal , Johnson, Michael , Koeleman, B.P.C. , Kunz, Wolfram W.S. , Marson, Anthony Guy , Sander, Josemir W , Sills, Graeme , Striano, Pasquale , Zara, Federico , Zimprich, Fritz , Weber, Yvonne Y.G. , Krause, Roland , Sisodiya, Sanjay , Schwab, Matthias , Sander, Thomas , Lerche, Holger
    Publication 2020-04-01
  • Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure Medications
    par Wolking, Stefan , Campbell, Ciarán , Stapleton, Caragh , McCormack, Mark , Delanty, Norman , Depondt, Chantal , Johnson, Michael , Koeleman, Bobby B.P.C. , Krause, Roland , Kunz, Wolfram W.S. , Marson, Anthony Guy , Sander, Josemir W , Sills, Graeme , Striano, Pasquale , Zara, Federico , Sisodiya, Sanjay , Cavalleri, Gianpiero , Lerche, Holger
    Publication 2021-06
  • Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrin.
    par Boothman, Isabelle , Clayton, Lisa M S , McCormack, Mark , Driscoll, Alexandra McKibben , Stevelink, Remi , Moloney, Patrick , Krause, Roland , Kunz, Wolfram W.S. , Diehl, Sarah , O'Brien, Terence , Sills, Graeme , de Haan, Gerrit Jan , Zara, Federico , Koeleman, B.P.C. , Depondt, Chantal , Marson, Anthony Guy , Stefansson, Hreinn , Stefansson, Kari , Craig, John , Johnson, Michael R , Striano, Pasquale , Lerche, Holger , Furney, Simon , Delanty, Norman , Consortium EpiPGX , Sisodiya, Sanjay M , Cavalleri, Gianpiero L
    Publication 2023-11-01
  • Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsy.
    par Wolking, Stefan , Moreau, Claudia , McCormack, Mark , Krause, Roland , Krenn, Martin , EpiPGx Consortium , Berkovic, Samuel F , Cavalleri, Gianpiero L , Delanty, Norman , Depondt, Chantal , Johnson, Michael R , Koeleman, B.P.C. , Kunz, Wolfgang Gerhard , Lerche, Holger , Marson, Anthony Guy , O'Brien, Terence , Petrovski, Slave , Sander, Josemir W , Sills, Graeme , Striano, Pasquale , Zara, Federico , Zimprich, Fritz , Sisodiya, Sanjay M , Girard, S , Cossette, Patrick
    Publication 2021-07-01
  • A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam
    par Campbell, Ciarán , McCormack, Mark , Patel, Sonn , Stapleton, Caragh , Bobbili, Dheeraj , Krause, Roland , Depondt, Chantal , Sills, Graeme , Koeleman, B.P.C. , Striano, Pasquale , Zara, Federico , Sander, Josemir W , Lerche, Holger , Kunz, Wolfram W.S. , Stefansson, Kari , Stefansson, Hreinn , Doherty, Colin P , Heinzen, Erin E.L. , Scheffer, Ingrid E , Goldstein, David B , O'Brien, Terence John , Cotter, David , Berkovic, Samuel F , Sisodiya, Sanjay , Delanty, Norman , Cavalleri, Gianpiero
    Publication 2021-01-01